2020-06-30 13:27:09 - WHO News

Public call for data on diagnostic accuracy on nucleic acid amplification tests to detect TB and resistance to selected anti-TB agents


Nucleic acid amplification tests (NAAT) are promising technologies for the rapid and accurate detection of TB and resistance to selected anti-TB agents. In December 2020, the World Health Organization (WHO) will convene a Guidelines Development Group (GDG) meeting to update its diagnostic guidelines on the use of NAATs to detect TB and resistance to selected anti-TB agents. Ahead of this meeting, WHO will commission reviews of relevant evidence on diagnostic accuracy for several NAAT assays.The following NAAT assays or classes of NAAT assays will be discussed by the GDG:Centralized assays that present end-to-end solutions for detection of TB and resistance to rifampicin and isoniazid (cDST: Index test 1);Cartridge-based technology for isoniazid and second-line drug resistance detection (XDR cartridge: Index test 2);Hybridization-based technology for pyrazinamide resistance detection (PZA LPA: Index test 3).To enable this process, WHO is issuing a public call for data, appealing to industry, researchers, national TB programmes and other agencies to provide suitable evidence for the performance of these technologies. The obtained data will be essential to facilitate the process of WHO policy updates.Please send relevant data by 1st August 2020, to ldr.policies@who.int. For more information on the parameters of the datasets, variables, and the process see below:Annex 1: Data requirementsIndex test 1: Centralized assays that present end-to-end solutions for detection of TB and resistance to rifampicin and isoniazid (cDST platforms).Desirable characteristics of the test: (a) Sample preparation workflow in (b) Automated DNA extr (c) Automated PCR prepa (d) Automated result interpre (c) Capacity per run: 24 (d) Time from sample to full MDR-TB diagnosis: 12 (e) Minimal desirable drug resistance detection: at least to INH and RIF.Study type: Clinical evaluation studies to confirm diagnostic performance on clinical samples.Study population: Random sample of unselected patients with signs and symptoms of TB, requiring evaluation for TB and/or resistance to isoniazid and rifampicin in sites of intended use.Reference standard: At a minimum, result of a single sputum culture and phenotypic DST, wherever applicable (liquid or solid, with speciation) should be included for each result of Index test 1. The use of a genotypic sequencing results where available will have an added value to confirm the presence of mutations in addition to phenotypic DST results.Index test 2: Cartridge-based technology for isoniazid and second-line drug resistance detection (XDR cartridge);Desirable characteristics of the test: (a) Automated real-time PCR; (b) Automated result interpre (b) Capacity per run: 4 (c) Time test results: 4 (d) Minimal desirable drug resistance detection: at least to INH and FQ.Study type: (a) Analytical validation studies measuring accuracy, precision, and reproducibility of the test in contrived specimens or panels, covering all key mutations to isoniazid and second-line drugs. (b) Clinical evaluation studies to confirm diagnostic performance on clinical samples.Study population: Patients with detected TB, requiring evaluation for resistance to isoniazid and second-line anti-TB agents in sites of intended use.Reference standard: At a minimum, result of a single sputum phenotypic DST (liquid or solid, with speciation) should be included for each result of Index test 2. The use of a genotypic sequencing results where available will have an added value to confirm the presence of mutations in addition to phenotypic DST results.Index test 3: Hybridization-based technology for pyrazinamide resistance detection (PZA LPA).Desirable characteristics of the test: (a) Automated or manual hybridization metho (b) Automated or manual result interpretation (c) Time from sample to test results: 24 (d) Minimal desirable drug resistance detection: at least to PZA.Study type: (a) Analytical validation studies measuring accuracy, precision, and reproducibility of the test in contrived specimens or panels, covering all key mutations to pyrazi (b) Clinical evaluation studies to confirm diagnostic performance on clinical s Study population: Patients with detected TB and resistance to rifampicin, requiring evaluation for resistance to pyrazinamide in sites of intended Reference standard: At a minimum, result of a single sputum phenotypic DST (liquid or solid, with speciation) should be included for each result of Index test 3. The use of a genotypic sequencing results where available will have an added value to confirm the presence of mutations in addition to phenotypic DST results.

Read on the original site






WHO
Study provides comprehensive view of terrestrial venomous snakes and snakebite in the Middle East
World Hepatitis Day: fast-tracking the elimination of hepatitis B among mothers and children
Cervical Cancer Elimination Initiative Updates
Addressing the crisis in antibiotic development
The World Health Organization reminds public to remain vigilant through Mr Bean’s Essential COVID-19 Checklist
Countries failing to prevent violence against children, agencies warn
First rituximab similar biotherapeutic products prequalified
The value of integrating HIV prevention and contraceptive services
Statement from Dr Mike Ryan, Executive Director, WHO Health Emergencies Programme at the Yemen High-level Pledging Conference
Maintaining essential health services: new operational guidance for the COVID-19 context
Basic Psychosocial Skills: A Guide for COVID-19 Responders
FIFA, European Commission and World Health Organization launch #SafeHome campaign to support those at risk from domestic violence
Historic health assembly ends with global commitment to COVID-19 response
Meeting of the Global Network of WHO Collaborating Centres for Bioethics
WHO and International Olympic Committee team up to improve health through sport
WHO and Costa Rica preview technology pooling initiative to ensure access to COVID-19 health products for all
Online Survey for Health Professionals on a Healthy Recovery from COVID-19
Research leads to actions improving childbirth in Guinea
Launch of the online courses on tobacco product regulation
Substantial investment needed to avert mental health crisis
Rasanews
5 Ways To Avoid Haram Music
Husayni mourners are at the forefront of the fight against the Coronavirus
With the support of Imam Khamenei and Hasan Nasrallah, the Deal of the Century won’t be ‎realized
No pilgrims allowed to enter Karbala on Ashura ‎
What is meant by the ‘Unity of Existence?’
Police deployed in Portland as protesters burn US flag
When Some People Don t Wear Masks, I Feel Ashamed Before The Devoted Nurse
Palestine will be liberated with the support of Imam Khamenei and Sayyid Hassan Nasrallah
The unity of Iran and Iraq thwarts US conspiracies against the region
The dignity of women in the Islamic legal system
The US is in the midst of an identity crisis and on the verge of collapse
Those who imposed sanctions to bring Iran to its knees admit their failure
Arab countries must not be silent about the choice of al-Quds as the capital of the Zionist ‎regime
Great, divine appreciation of the chosen Messenger of God, Prophet Abraham (pbuh)
Forcing Iran into bankruptcy enemy’s ‎long-term ploy
The Islamic Awakening in West Asia and North Africa and the Reactions of the ‎United States
A look in to the existential philosophy of ‘Id al-Adha from the viewpoint of ‎Ayatollah Makarem-Shirazi
Recognize the tricks of the enemies in creating distance between believers and humanizing ‎resources
Examining the teachings of the Supplication of Arafah from the viewpoint of ‎Ayatollah ‎Makarem-Shirazi
Martyrdom anniversary of Muslim ibn Aqil
WHO News
Statement on the fourth meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of coronavirus disease (COVID-19)
COVID-19 Emergency Committee highlights need for response efforts over long term
World Breastfeeding Week 2020 Message
WHO, WIPO, WTO launch updated study on access to medical technologies and innovation
INFOSAN Quarterly Summary, 2020 #2
Framework for the evaluation of new tests for tuberculosis infection
Children are the key to behaviour change to reduce infection
WHO statement on heated tobacco products and the US FDA decision regarding IQOS
European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings
Amid continued progress, trachoma elimination programmes set their sights on 2030
New estimates show worldwide fall in unintended pregnancies since 1990-1994
Call for expressions of interest: Systematic reviews on dose optimization of the first-line TB medicines
New COVID-19 Law Lab to provide vital legal information and support for the global COVID-19 response
WHA Report on addressing the burden of epilepsy and other neurological disorders available online
Eleven New Psychoactive Substances to be considered for international control by 43rd ECDD
The latest list of participants of the WHO Chemical Risk Assessment Network
Cervical Cancer Elimination Initiative Updates
Neglected tropical diseases of the skin: WHO launches mobile application to facilitate diagnosis
WHO Director-General pays tribute to Spain’s sacrifices and leadership to confront COVID-19
More than 150 countries engaged in COVID-19 vaccine global access facility
RT
Russia legalizes cryptocurrencies, but don t hurry to shop with bitcoin
Poland’s top court confirms Duda as president, sees complaints insufficient to void election results
Brexit to blame? Britons miffed after poll shows most EU citizens WOULD NOT help UK in a crisis
Russia vows to prosecute Nazi collaborators behind World War Two GENOCIDE for crimes committed over 75 years ago
Duterte agrees to place Philippines’ capital, outlying provinces back under lockdown from Tuesday after medics’ advice
They went after a sick, disabled man : MMA pirate who faced $32 MILLION fine slams UFC while insisting he ISN T sorry
There might never be a ‘silver bullet’ for Covid-19, WHO chief warns
WATCH: Lovren teases tight Salah over new haircut as pals catch up on FaceTime after defender joins Russian champions Zenit
Pakistan’s mediation between Iran Saudi Arabia at US request is going slowly, PM Khan says
Portland records highest number of monthly murders in ‘OVER 30 YEARS’ as city slashes police budget
Apple sued by Chinese AI company for copyright infringement
Israeli jets strike Hamas targets in Gaza after ‘rocket attack’
Australia’s Victoria state tightens lockdown measures
Vietnam has no plans for nationwide lockdown, says August is ‘decisive’ in containing coronavirus
Russia s Pavlyuchenkova becomes first women s champ in Ultimate Tennis Showdown event set up by Serena coach hyped by Mike Tyson
At least 29 killed, more than 50 wounded as ISIS storms Afghan jail to free prisoners
Mass production of first Russian electric car to start by end of year
Karma : First NBA star not to kneel since league restart is cruelly TAUNTED as he exits in wheelchair with knee injury (VIDEO)
‘Totally unacceptable’: Mayor Khan tears into PM Johnson for leaving him out of London’s Covid-19 second wave planning
French PM urges vigilance as major cities make mask-wearing outdoors compulsory in many areas